The state of Florida currently has 29 active clinical trials seeking participants for Type 2 Diabetes research studies. These trials are conducted in various cities, including Miami, Tampa, Jacksonville and Orlando.
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
NCT06533527
Recruiting
To assess whether holding incretin-based therapy before endoscopy reduces the likelihood of clinically relevant Residual Gastric Volume (RGV). Primary Outcomes: * Residual gastric volume that precludes adequate endoscopic examination * Residual gastric volume that necessitates premature termination of the endoscopy procedure * Need for endotracheal intubation due to stomach contents. * Occurrence of aspiration events requiring extended observation/monitoring, unplanned therapeutics, and/or hos... Read More
Gender:
ALL
Ages:
All
Trial Updated:
02/17/2025
Locations: Cleveland Clinic, Weston, Florida
Conditions: Diabetes Mellitus, Type 2, Obesity, Gastroparesis
Register for Updates
Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes
NCT04754581
Recruiting
The overall aim of this pilot study is to investigate the effects of exercise training on skeletal muscle and adipose tissue insulin resistance in subjects with Type 2 Diabetes (T2D).
Gender:
ALL
Ages:
Between 30 years and 65 years
Trial Updated:
09/26/2024
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Type 2 Diabetes
Register for Updates
Pharmacist-led Continuous Glucose Monitoring
NCT06572306
Recruiting
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/26/2024
Locations: USF Health Department of Family Medicine - Morsani Center for Advanced Health Care, Tampa, Florida +1 locations
Conditions: Type 2 Diabetes
Register for Updates
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
NCT06567795
Recruiting
To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
08/21/2024
Locations: Metabolic Research Institute, Inc, West Palm Beach, Florida
Conditions: Diabetes Mellitus Type 2, Cardiovascular Diseases, Coronary Artery Disease, Cerebrovascular Disease, Peripheral Artery Disease
Register for Updates
RESET System Pivotal Trial (Rev F)
NCT04101669
Recruiting
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the RESET System for Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study. A multi-center, double-blinded, randomized, sham-controlled trial to evaluate the safety and effectiveness of the RESET System plus moderate intensity lifestyle and dietary counseling compliant with 2024 ADA Standard of Care as compared to a sham control receiving moderate intensity lifestyle an... Read More
Gender:
ALL
Ages:
Between 22 years and 65 years
Trial Updated:
07/16/2024
Locations: University of Miami Hospital, Miami, Florida
Conditions: Diabetes type2, Obesity
Register for Updates